D000697Chemicals & DrugsD27.505.696.282D27.505.954.427.2204100.99294Central Nervous System Stimulantscmhprofilesont:personsuffixperson suffixFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentDivisionvivo:hrJobTitleHR job titleInformation Resourcevivo:orcidIdORCID idPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson18840375Kennedy MJ, Davis DA, Smith N, Gaedigk A, Pearce RE, Kearns GLClinical therapeuticsKennedy MJ, Davis DA, Smith N, Gaedigk A, Pearce RE, Kearns GL. Six-month, prospective, longitudinal, open-label caffeine and dextromethorphan phenotyping study in children with growth hormone deficiency receiving recombinant human growth hormone replacement. Clin Ther. 2008 Sep; 30(9):1687-99.Clin Ther2008-09-01T00:00:002008Six-month, prospective, longitudinal, open-label caffeine and dextromethorphan phenotyping study in children with growth hormone deficiency receiving recombinant human growth hormone replacement.23855716Sutter ME, Gaedigk A, Albertson TE, Southard J, Owen KP, Mills LD, Diercks DBClinical toxicology (Philadelphia, Pa.)Sutter ME, Gaedigk A, Albertson TE, Southard J, Owen KP, Mills LD, Diercks DB. Polymorphisms in CYP2D6 may predict methamphetamine related heart failure. Clin Toxicol (Phila). 2013 Aug; 51(7):540-4.Clin Toxicol (Phila)2013-07-15T00:00:002013Polymorphisms in CYP2D6 may predict methamphetamine related heart failure.27052878Dinh JC, Pearce RE, Van Haandel L, Gaedigk A, Leeder JSDrug metabolism and disposition: the biological fate of chemicalsDinh JC, Pearce RE, Van Haandel L, Gaedigk A, Leeder JS. Characterization of Atomoxetine Biotransformation and Implications for Development of PBPK Models for Dose Individualization in Children. Drug Metab Dispos. 2016 07; 44(7):1070-9.Drug Metab Dispos2016-04-06T00:00:002016Characterization of Atomoxetine Biotransformation and Implications for Development of PBPK Models for Dose Individualization in Children.3Assistant Professor1ProfessorPhD, MSHung-WenYehHung-Wen Yeh0.000000000000000.00000000000000136Yeh, Hung-Wen0000-0002-9904-3275Research Faculty PhDPediatricsResearchPhD, MSAndreaGaedigkAndrea Gaedigk39.08346750000000-94.577112900000001Gaedigk, Andrea0000-0001-6968-1893Director, Pharmacogenetics Core LaboratoryPharmD, PhDJ. StevenLeederJ. Steven Leeder39.08346750000000-94.5771129000000034Leeder, J. Steven0000-0001-6688-0504Deputy Director, Children's Research InstituteChildren's Mercy Kansas City0.6355630.2109754research area of0.8568640.042501810subject area forPhDCraigSmailCraig Smail0.000000000000000.00000000000000187Smail, Craig0000-0001-8045-6021Computational Research Faculty32925567Loskutova NY, Lutgen C, Smail C, Staton EW, Nichols SD, Pinckney RGJournal of patient safetyLoskutova NY, Lutgen C, Smail C, Staton EW, Nichols SD, Pinckney RG. Stimulant Prescribing Error Assessment Rubric Development. J Patient Saf. 2022 01 01; 18(1):e282-e289.J Patient Saf2022-01-01T00:00:002022Stimulant Prescribing Error Assessment Rubric Development.34798853Paulus MP, Kuplicki R, Victor TA, Yeh HW, Khalsa SSBMC psychiatryPaulus MP, Kuplicki R, Victor TA, Yeh HW, Khalsa SS. Methylphenidate augmentation of escitalopram to enhance adherence to antidepressant treatment: a pilot randomized controlled trial. BMC Psychiatry. 2021 11 19; 21(1):582.BMC Psychiatry2021-11-19T00:00:002021Methylphenidate augmentation of escitalopram to enhance adherence to antidepressant treatment: a pilot randomized controlled trial.true1Research Faculty PhDResearch Faculty PhDtrue1Director, Pharmacogenetics Core LaboratoryDirector, Pharmacogenetics Core Laboratorytrue1Computational Research FacultyComputational Research Facultytrue1Deputy Director, Children's Research InstituteDeputy Director, Children's Research Institute